Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4
Marloes Stam, Camiel A. Wijngaarde, Bart Bartels, et al.
Brain Communications (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Measuring Fatigue and Fatigability in Spinal Muscular Atrophy (SMA): Challenges and Opportunities
Rafael Rodriguez‐Torres, David Uher, Emma Gay, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3458-3458
Open Access | Times Cited: 17
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians
Sithara Ramdas, Maryam Oskoui, Laurent Servais
Drugs (2024) Vol. 84, Iss. 7, pp. 747-762
Closed Access | Times Cited: 5
Targeting neuromuscular junction to treat neuromuscular disorders
Rizwan Qaisar
Life Sciences (2023) Vol. 333, pp. 122186-122186
Closed Access | Times Cited: 11
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges
Umme Sabrina Haque, Toshifumi Yokota
Genes (2024) Vol. 15, Iss. 8, pp. 999-999
Open Access | Times Cited: 4
Pushing the boundaries: future directions in the management of spinal muscular atrophy
Fiona Moultrie, Laura Chiverton, Isabel Hatami, et al.
Trends in Molecular Medicine (2025)
Open Access
Spinal Muscular Atrophy (SMA): Treatment strategies, challenges and future prospects
Nikunja Kishor Mishra, Amiyakanta Mishra
Deleted Journal (2025), pp. 100031-100031
Closed Access
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges
Umme Sabrina Haque, Toshifumi Yokota
(2024)
Open Access | Times Cited: 3
Six‐minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen
Alessandra Govoni, Giulia Ricci, Silvia Bonanno, et al.
Muscle & Nerve (2024)
Open Access | Times Cited: 2
Treatment strategies for patients with spinal muscular atrophy
Liesbeth De Waele, Laurent Servais
Expert Review of Neurotherapeutics (2024), pp. 1-3
Open Access | Times Cited: 2
Enhanced low-threshold motor unit capacity during endurance tasks in patients with spinal muscular atrophy using pyridostigmine
Laura E. Habets, Bart Bartels, Jeroen A. L. Jeneson, et al.
Clinical Neurophysiology (2023) Vol. 154, pp. 100-106
Open Access | Times Cited: 6
Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series
Alessia Pugliese, Adela Della Marina, Eduardo de Paula Estephan, et al.
Journal of Neurology (2023) Vol. 271, Iss. 3, pp. 1331-1341
Closed Access | Times Cited: 5
Fatigue in Spinal Muscular Atrophy: a fundamental open issue.
Oscar Crisafulli, Angela Berardinelli, Giuseppe D’Antona
PubMed (2024) Vol. 43, Iss. 1, pp. 1-7
Closed Access | Times Cited: 1
Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3
Danny R van der Woude, Renske I Wadman, Fay-Lynn Asselman, et al.
Neuromuscular Disorders (2024) Vol. 41, pp. 1-7
Open Access | Times Cited: 1
Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction
Francesca Torri, Michelangelo Mancuso, Gabriele Siciliano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7311-7311
Open Access | Times Cited: 1
Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy
Vera Dobelmann, Andreas Roos, Andreas Hentschel, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 7000-7011
Open Access | Times Cited: 1
Performance fatigability in adults with spinal muscular atrophy treated long‐term with nusinersen
Benjamin Stolte, Svenja Neuhoff, Jaqueline Lipka, et al.
Muscle & Nerve (2024)
Open Access | Times Cited: 1
Spinal Muscular Atrophy: Current Medications and Re-purposed Drugs
S Basak, Nupur Biswas, Jaya M. Gill, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access
Spinal Muscular Atrophy
Satish V. Khadilkar, Rakhil S. Yadav, Bhagyadhan A. Patel
Neuromuscular Disorders (2024), pp. 157-176
Closed Access
Page 1

Scroll to top